From February 7, 2024 to March 31, 2024, the company has repurchased 2,577,000 shares, representing 0.48% for KRW 7,400.24 million. With this, the company has completed the repurchase of 2,577,000 shares, representing 0.48% for KRW 7,400.24 million under the buyback announced on February 7, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,668 JPY | 0.00% | +0.45% | +12.55% |
May. 02 | BridgeBio Pharma Shares Decline After Q1 Financial Results | MT |
Apr. 08 | U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease | RE |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.55% | 9.06B | |
+4.30% | 69.17B | |
-12.75% | 4.96B | |
+42.38% | 4.47B | |
+5.23% | 3.9B | |
+21.52% | 2.41B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B | |
+4.60% | 1.65B |
- Stock Market
- Equities
- 4151 Stock
- News Kyowa Kirin Co. Ltd.
- Tranche Update on Kyowa Kirin Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024.